NCT07535242 is a clinical trial in Multiple Sclerosis, sponsored by Ondokuz Mayıs University.

Who is sponsoring NCT07535242?

NCT07535242 is sponsored by Ondokuz Mayıs University.

What condition does NCT07535242 study?

NCT07535242 studies Multiple Sclerosis.

Is NCT07535242 still recruiting?

NCT07535242 is currently not yet recruiting. Last updated 17 April 2026.

Last reviewed 2026-04-17 · How we verify

NCT07535242

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Serum GFAP, NfL, VEGF and Clinical Progression in Progressive MS

Not yet recruiting Last updated 17 April 2026

What this trial tests

trial in Multiple Sclerosis in 22 participants. Not yet recruiting.

Timeline

21 April 2026

Primary endpoint
30 April 2026

5 May 2026

Quick facts

Lead sponsor	Ondokuz Mayıs University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	22
Start date	21 April 2026
Primary completion	30 April 2026
Estimated completion	5 May 2026

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Ondokuz Mayıs University

Who can join

Adults 18 to 60, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate whether the biomarkers GFAP, NfL, and VEGF-recently considered important guides for better understanding the pathophysiology of MS-also serve as indicators of clinical progression in MS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Ondokuz Mayıs University trials

Trials by the same sponsor.

NCT07500389 — Postural Habits, Body Awareness, and Functional Performance Across BMI Categories in Women · not yet recruiting
NCT07504848 — Stroke Mobility and Caregiver Outcomes · not yet recruiting
NCT07525557 — Kinesiophobia, Pain and Disability in Chronic Neck Pain · recruiting
NCT07497802 — Mindfulness-Based Psychoeducation for Women With Gynecological Cancer · NA · not yet recruiting
NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07535242 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ondokuz Mayıs University
Last refreshed: 17 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07535242.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing